Impact of short term oral steroid use for intravenous contrast media hypersensitivity prophylaxis in diabetic patients undergoing nonemergent coronary angiography or interventions.
Bashar S AmrMatthew R LippmannPatrick TobbiaNicholas IsomTarun DaliaTyler BuechlerMichael PierpolineNilay PatelEric HockstadMark WileyPeter TadrosAshwani MehtaMatthew EarnestJohn G ChenKamal GuptaPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2019)
Short-term steroid use for ICMH results in a significant increase in surrogate markers for adverse clinical events after coronary procedures. Study findings highlight the need for better periprocedural management of these patients and to limit steroid prophylaxis to those with only true ICMH.
Keyphrases
- patients undergoing
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- coronary artery disease
- magnetic resonance
- type diabetes
- peritoneal dialysis
- prognostic factors
- heart failure
- emergency department
- low dose
- atrial fibrillation
- acute coronary syndrome
- patient reported outcomes
- left ventricular
- aortic valve
- patient reported
- aortic stenosis